Navigation Links
Covance Elects Dr. Gary E. Costley to Board of Directors
Date:9/27/2007

PRINCETON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it has elected Dr. Gary E. Costley to its Board of Directors.

Dr. Costley adds further executive management experience to the Covance Board of Directors, as well as extensive scientific depth in nutritional chemistry, food safety and drug discovery services. He was Chairman and Chief Executive Officer of International Multifoods Corporation, manufacturer of branded consumer food and foodservice products. He also spent 25 years at the Kellogg Company in roles of increasing global responsibility in the areas of nutrition research and product development, public affairs and executive management. Dr. Costley is a co-founder and currently managing director of C&G Capital Management, LLC, which provides capital and management to health, medical and nutritional products and services companies.

Dr. Costley is a board member for three other public companies: Prestige Brand Holdings, Inc., a company that develops and markets over-the-counter drugs, household cleaning products and personal care items; Principal Financial Group, Inc., a financial and asset management company; and Tiffany and Co., a holding company for Tiffany and Company, a jewelry and specialty retailer. He also previously held board memberships in Accelrys, Inc. and Pharmacopeia Drug Discovery, Inc., organizations specializing in products and services that improve and accelerate drug discovery and chemical development.

"I am very pleased to welcome Dr. Gary Costley to the Covance Board of Directors. Dr. Costley's successful track record in leading global public companies brings tremendous value to Covance's board," said Joe Herring, Covance Chairman and Chief Executive Officer. "His strong scientific background in food product development and nutrition research will also enhance Covance's ability to respond to the increasing global demand for food safety testing."

Dr. Costley earned a B.S. in animal science, and a M.S. and Ph.D. in Nutrition, with minors in Physiology and Biochemistry from Oregon State University.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.3 billion, global operations in more than 20 countries, and more than 8,400 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.


'/>"/>
SOURCE Covance Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woman Elects For Mastectomy: Prolonged Wait For Genetic Results
2. United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
3. Study casts doubt on keyboard ills
4. Who Board To Discuss Asian Tsunami Related Health Issues
5. Abdominal Crunches Not The Best Option For Wash Board Abs.
6. Computer Keyboards In Hospitals Could Spread Infection To Patients
7. Flu, Boarded A Ship?
8. Skateboarding to health
9. Shangai Citizens to Monitor Billboards
10. Budhia Is Fine, Government-constituted Medical Board Reports False
11. Pharmacy Board Says Pharmacists Have Right To Refuse Morning-After Pill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
Breaking Medicine Technology: